AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria.
Saved in:
| Title: | AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria. |
|---|---|
| Authors: | Richards DY; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA., Winn SR; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA., Dudley S; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA., Nygaard S; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA., Mighell TL; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA., Grompe M; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA., Harding CO; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USA. |
| Source: | Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2019 Dec 24; Vol. 17, pp. 234-245. Date of Electronic Publication: 2019 Dec 24 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
